BD announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY investigational device exemption (IDE) ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY Investigational Device ...

Several balloon-expandable stents have been used in the iliac artery, however, they have not had a primary indication for iliac stenting. The Express® LD iliac premounted stent system (Boston ...

Vascular. 2007;15(1):5-11. According to Ballard and colleagues, factors such as female sex, superficial femoral artery occlusion, perioperative vascular complications, and hypercholesterolemia proved ...

Please provide your email address to receive an email when new articles are posted on . LAS VEGAS — Self-expanding and balloon-expandable stents were equally safe and effective in patients with iliac ...

Stenting of iliac artery disease in patients with severely calcified lesions or extensive peripheral artery disease (PAD)—who historically have been excluded from clinical trials—is safe and effective ...

Background A 66-year-old man presented to hospital with gross hematuria and clots. He had previously undergone surgical repair of a right iliac artery aneurysm with placement of a vascular prosthesis ...

Please provide your email address to receive an email when new articles are posted on . HOLLYWOOD, Fla. — Approved by the FDA in late January, the first balloon-expandable stent graft with an ...

The FDA signed off on its Omnilink Elite vascular balloon-expandable stent system to treat iliac artery disease. The indication addresses a form of peripheral artery disease that can specifically hit ...

DUBLIN -- Medtronic plc today announced that its Protégé(TM) GPS(TM) self-expanding peripheral stent system has received approval from the U.S. Food and Drug Administration (FDA) for the treatment of ...

BD (NYSE: BDX) today announced that it completed enrollment in the iliac artery patient cohort in its pivotal AGILITY study.